{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T22:15:50Z","timestamp":1764713750660,"version":"3.43.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:p>Pediatric Hepatoblastoma is a rare malignancy of the liver. This study used the National Cancer Database (NCDB) to identify 1068 patients diagnosed with hepatoblastoma from 2004 to 2020. \u03c7<jats:sup>2<\/jats:sup> and Analysis of Variance testing, as well as Kaplan-Meier, Cox Regression, and multinomial logistic regression models were used. Data was analyzed using SPSS version 27, and statistical significance was set at \u03b1=0.05. Our results found Black patients experienced a significantly lower median survival rate compared with White patients, a difference which persisted after controlling for covariates. Black patients were also less likely to receive surgery and chemotherapy and more likely to be from low-income households than White patients. White patients had a significantly shorter inpatient hospital stay compared to Black patients and were more likely to receive treatment at more than 1 CoC accredited facility. There was no significant difference in grade, size of tumor, metastasis, or time of diagnosis to surgery. This study showed Black patients experienced inferior overall survival when diagnosed and treated for hepatoblastoma compared to White patients.<\/jats:p>","DOI":"10.1097\/mph.0000000000002918","type":"journal-article","created":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T15:48:23Z","timestamp":1720540103000},"page":"e381-e386","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Racial Disparities in Treatment and Outcomes of Pediatric Hepatoblastoma"],"prefix":"10.1097","volume":"46","author":[{"given":"Taylor","family":"Billion","sequence":"first","affiliation":[{"name":"Creighton University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Braaten","sequence":"additional","affiliation":[{"name":"Creighton University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Holland","sequence":"additional","affiliation":[{"name":"Creighton University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjali","family":"Mishra","sequence":"additional","affiliation":[{"name":"Creighton University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rimzhim","family":"Kashikar","sequence":"additional","affiliation":[{"name":"Creighton University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Silberstein","sequence":"additional","affiliation":[{"name":"Creighton University Department of Hematology & Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abubakar","family":"Tauseef","sequence":"additional","affiliation":[{"name":"Creighton University Department of Internal Medicine, Omaha, NE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noureen","family":"Asghar","sequence":"additional","affiliation":[{"name":"Creighton University Department of Internal Medicine, Omaha, NE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley","family":"DeVrieze","sequence":"additional","affiliation":[{"name":"Creighton University Department of Internal Medicine, Omaha, NE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohsin","family":"Mirza","sequence":"additional","affiliation":[{"name":"Creighton University Department of Internal Medicine, Omaha, NE"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,7,5]]},"reference":[{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.3390\/cancers11121944","article-title":"Surgical management of hepatoblastoma and recent advances","volume":"11","author":"Yang","year":"2019","journal-title":"Cancers"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/hpb.12112","article-title":"Predictors of survival and incidence of hepatoblastoma in the paediatric population","volume":"15","author":"Allan","year":"2013","journal-title":"HPB (Oxford)"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/pbc.24217","article-title":"Hepatoblastoma clinical research: Lessons learned and future challenges","volume":"59","author":"Perilongo","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S1470-2045(16)30598-8","article-title":"Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children\u2019s Hepatic Tumors International Collaboration","volume":"18","author":"Meyers","year":"2017","journal-title":"Lancet Oncol"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/cncr.34014","article-title":"Doxorubicin in combination with cisplatin, 5-flourouracil, and vincristine is feasible and effective in unresectable hepatoblastoma: A Children\u2019s Oncology Group study","volume":"128","author":"Katzenstein","year":"2022","journal-title":"Cancer"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S1470-2045(18)30895-7","article-title":"Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): A Children\u2019s Oncology Group, multicentre, phase 3 trial","volume":"20","author":"Katzenstein","year":"2019","journal-title":"Lancet Oncol"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1002\/cncr.30591","article-title":"Vincristine\/irinotecan upfront window treatment of high-risk hepatoblastoma: A report from the Children\u2019s Oncology Group (COG) AHEP0731 study committee","volume":"123","author":"Katzenstein","year":"2017","journal-title":"Cancer"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejca.2015.09.023","article-title":"The Children\u2019s Hepatic tumors International Collaboration (CHIC): Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model","volume":"52","author":"Czauderna","year":"2016","journal-title":"European J Cancer"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"e29763","DOI":"10.1002\/pbc.29763","article-title":"Incidence and 5-year survival of children and adolescents with hepatoblastoma in the United States","volume":"69","author":"Kahla","year":"2022","journal-title":"Pediatr Blood Cancer"},{"key":"R11-20250804","first-page":"62","article-title":"Incidence trends and survival prediction of hepatoblastoma in children: A population-based study","volume":"39","author":"Feng","year":"2019","journal-title":"Cancer Commun (Lond)"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/pbc.24215","article-title":"The epidemiology of hepatoblastoma","volume":"59","author":"Spector","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00383-009-2349-3","article-title":"Survival trends in children with hepatoblastoma","volume":"25","author":"Horton","year":"2009","journal-title":"Pediatr Surg Int"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/cncr.28617","article-title":"Lack of reduction in racial disparities in cancer-specific mortality over a 20-year period","volume":"120","author":"Aizer","year":"2014","journal-title":"Cancer"},{"key":"R15-20250804","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1002\/cncr.33678","article-title":"Racial and ethnic disparities in pediatric cancer incidence among children and young adults in the United States by single year of age","volume":"127","author":"Marcotte","year":"2021","journal-title":"Cancer"},{"key":"R16-20250804","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1158\/1055-9965.EPI-21-0117","article-title":"Racial\/ethnic disparities in childhood cancer survival in the United States","volume":"30","author":"Zhao","year":"2021","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R17-20250804","doi-asserted-by":"crossref","first-page":"e28738","DOI":"10.1002\/pbc.28738","article-title":"Racial and ethnic disparities in survival of children with brain and central nervous tumors in the United States","volume":"68","author":"Haizel-Cobbina","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"R18-20250804","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1038\/s41598-020-61237-2","article-title":"Population-based analysis of demographic and socioeconomic disparities in pediatric CNS cancer survival in the United States","volume":"10","author":"Fineberg","year":"2020","journal-title":"Sci Rep"},{"key":"R19-20250804","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1001\/jamapediatrics.2019.6074","article-title":"Associations between race\/ethnicity and US childhood and adolescent cancer survival by treatment amenability","volume":"174","author":"Delavar","year":"2020","journal-title":"JAMA Pediatr"},{"key":"R20-20250804","doi-asserted-by":"crossref","first-page":"4379","DOI":"10.1002\/cncr.33080","article-title":"Pediatric cancer mortality and survival in the United States, 2001-2016","volume":"126","author":"Siegel","year":"2020","journal-title":"Cancer"},{"key":"R21-20250804","first-page":"1","article-title":"Racial disparities and sociodemographic differences in incidence and survival among pediatric patients in the United States with primary liver cancer","volume":"52","author":"Nautsch","year":"2017","journal-title":"J Clin Gastroenterol"},{"key":"R22-20250804","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/pan.13993","article-title":"Epidemiology of pediatric surgery in the United States","volume":"30","author":"Rabbitts","year":"2020","journal-title":"Pediatric Anesthesia"},{"key":"R23-20250804","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1001\/jamasurg.2020.6257","article-title":"Racial disparities in the use of surgical procedures in the US","volume":"156","author":"Best","year":"2021","journal-title":"JAMA Surg"},{"key":"R24-20250804","doi-asserted-by":"crossref","first-page":"e2021054634","DOI":"10.1542\/peds.2021-054634","article-title":"A structural racism framework to guide health equity interventions in pediatric oncology","volume":"149","author":"Umaretiya","year":"2022","journal-title":"Pediatrics"},{"key":"R25-20250804","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.jpedsurg.2013.01.043","article-title":"The effect of race and gender on pediatric surgical outcomes within the United States","volume":"48","author":"Stone","year":"2013","journal-title":"J Pediatr Surg"},{"key":"R26-20250804","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/cncr.33268","article-title":"Role of implicit bias in pediatric cancer clinical trials and enrollment recommendations among pediatric oncology providers","volume":"127","author":"Graetz","year":"2020","journal-title":"Cancer"},{"key":"R27-20250804","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1182\/blood-2014-01-552166","article-title":"6MP adherence in a multiracial cohort of children with acute lymphoblastic leukemia: A Children\u2019s Oncology Group study","volume":"124","author":"Bhatia","year":"2014","journal-title":"Blood"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002918","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:05:15Z","timestamp":1754337915000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,5]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002918","relation":{},"ISSN":["1077-4114"],"issn-type":[{"type":"print","value":"1077-4114"}],"subject":[],"published":{"date-parts":[[2024,7,5]]},"assertion":[{"value":"2023-12-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}